Literature DB >> 17936528

Apoptotic effect of Oldenlandia diffusa on the leukaemic cell line HL60 and human lymphocytes.

Shaun Willimott1, James Barker, Lucy A Jones, Elizabeth I Opara.   

Abstract

Oldenlandia diffusa is traditionally prescribed in the treatment of a number of cancers and studies suggest that it exerts a cytotoxic action specific to cancer cells. To further investigate this suggested action, the effect(s) of Oldenlandia diffusa on leukaemic cells (HL60) and stimulated and unstimulated human blood lymphocytes (PBLs) was investigated. For the HL60s, cell growth, apoptotic induction, alterations in cell cycle characteristics and genotoxicity were investigated. For the PBLs, apoptotic induction and alterations in cell cycle characteristics were investigated. Preliminary chemical analysis to identify the cytotoxic constituents of Oldenlandia diffusa was also carried out. Results showed that Oldenlandia diffusa significantly inhibited the growth of the HL60s and induced apoptosis in a cell cycle-independent fashion, possibly through the induction of genotoxic damage. Oldenlandia diffusa did not induce apoptosis in the PBLs however progression through the cell cycle was not evident (in stimulated PBLs) suggesting some degree of cytotoxicity. Preliminary chemical analysis indicated that a number of compounds appear to be responsible for the cytotoxic action of Oldenlandia diffusa. These results indicate that HL60s are more sensitive to Oldenlandia diffusa than stimulated PBLs and thus support a cytotoxic action for Oldenlandia diffusa that has some degree of specificity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17936528     DOI: 10.1016/j.jep.2007.08.030

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  8 in total

1.  In Vitro Ultramorphological Assessment of Apoptosis on CEMss Induced by Linoleic Acid-Rich Fraction from Typhonium flagelliforme Tuber.

Authors:  Syam Mohan; Ahmad Bustamam; Siddig Ibrahim; Adel S Al-Zubairi; Mohammed Aspollah; Rasedee Abdullah; Manal Mohamed Elhassan
Journal:  Evid Based Complement Alternat Med       Date:  2011-05-02       Impact factor: 2.629

2.  Oldenlandia diffusa Promotes Antiproliferative and Apoptotic Effects in a Rat Hepatocellular Carcinoma with Liver Cirrhosis.

Authors:  Yun-Young Sunwoo; Jin-Hee Lee; Ho Yong Jung; Yu Jin Jung; Moon-Seo Park; Yong-An Chung; Lee-So Maeng; Young-Min Han; Hak Soo Shin; Jisoo Lee; Sang In Park
Journal:  Evid Based Complement Alternat Med       Date:  2015-03-10       Impact factor: 2.629

3.  Aqueous Oldenlandia diffusa extracts inhibits colorectal cancer cells via activating AMP-activated protein kinase signalings.

Authors:  Pei-Hua Lu; Min-Bin Chen; Chao Ji; Wen-Ting Li; Mu-Xin Wei; Mian-Hua Wu
Journal:  Oncotarget       Date:  2016-07-19

Review 4.  Oleanolic Acid Alters Multiple Cell Signaling Pathways: Implication in Cancer Prevention and Therapy.

Authors:  Lovro Žiberna; Dunja Šamec; Andrei Mocan; Seyed Fazel Nabavi; Anupam Bishayee; Ammad Ahmad Farooqi; Antoni Sureda; Seyed Mohammad Nabavi
Journal:  Int J Mol Sci       Date:  2017-03-16       Impact factor: 5.923

Review 5.  The potential of plant extracts in cell therapy.

Authors:  Caifeng Li; Zhao Cui; Shiwen Deng; Peng Chen; Xianyu Li; Hongjun Yang
Journal:  Stem Cell Res Ther       Date:  2022-09-14       Impact factor: 8.079

6.  An in vitro based investigation of the cytotoxic effect of water extracts of the Chinese herbal remedy LD on cancer cells.

Authors:  Shaun Willimott; James Barker; Lucy A Jones; Elizabeth I Opara
Journal:  Chem Cent J       Date:  2009-09-28       Impact factor: 4.215

7.  The synergistic anticancer effect of cisplatin combined with Oldenlandia diffusa in osteosarcoma MG-63 cell line in vitro.

Authors:  Feifei Pu; Fengxia Chen; Song Lin; Songfeng Chen; Zhicai Zhang; Baichuan Wang; Zengwu Shao
Journal:  Onco Targets Ther       Date:  2016-01-11       Impact factor: 4.147

8.  A Network Pharmacology Approach to Uncover the Multiple Mechanisms of Hedyotis diffusa Willd. on Colorectal Cancer.

Authors:  Xinkui Liu; Jiarui Wu; Dan Zhang; Kaihuan Wang; Xiaojiao Duan; Xiaomeng Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2018-02-12       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.